This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DARA Biosciences Inc (DARA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 3.43M 6.50M 1.18M 5.48M
Receivables 174.09K 173.38K 0.00 0.00
Inventories 104.09K 125.28K 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 3.89M 7.04M 1.46M 5.83M
Property, Plant & Equipment, Gross 215.70K 203.49K 187.82K 190.57K
Accumulated Depreciation & Depletion 175.09K 153.30K 145.37K 127.22K
Property, Plant & Equipment, Net 40.61K 50.19K 42.46K 63.36K
Intangibles 3.22M 3.71M 0.00 0.00
Other Non-Current Assets 12.88K 67.31K 347.02K 549.20K
Total Non-Current Assets 4.10M 4.65M 389.48K 612.56K
Liabilities & Shareholder Equity
Total Assets 7.99M 11.69M 1.85M 6.44M
Accounts Payable 619.57K 1.38M 640.82K 349.74K
Short Term Debt 3.92K 7.17K 15.31K 13.22K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 1.68M 2.04M 868.00K 914.80K
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 72.73K 40.86K 9.10K 12.05K
Other Non-Current Liabilities 662.22K 599.45K 0.00 287.62K
Minority Interest -402.81K -429.34K -306.66K -339.49K
Total Non-Current Liabilities -296.45K 15.64K -190.09K 422.45K
Total Liabilities 1.38M 2.05M 677.90K 1.34M
Preferred Stock Equity 7.00 19.00 8.00 37.00
Common Stock Equity 6.61M 9.64M 1.17M 5.11M
Common Par 309.74K 189.47K 56.01K 41.26K
Additional Paid In Capital 63.29M 56.43M 40.83M 38.61M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -56.99M -47.03M -39.72M -33.55M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 45.47K 0.00 0.00
Total Capitalization 6.61M 9.64M 1.17M 5.11M
Total Equity 6.61M 9.64M 1.17M 5.11M
Total Liabilities & Stock Equity 7.99M 11.69M 1.85M 6.44M
Total Common Shares Outstanding 6.19M 3.79M 1.12M 825.20K
Preferred Shares 728.00 1.94K 828.00 3.68K
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 5.13M 2.42M 1.03M 626.34K
Diluted Weighted Shares Outstanding 5.13M 2.42M 1.03M 626.34K
Number of Employees 13 17 8 5
Number of Part-Time Employees 1 1 1 1

DARA DARA Biosciences Inc

Analysts Ratings for DARA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

DARA Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs